Skip to main content

Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe

Obiettivo

"Traumatic brain injury (TBI) is among the leading causes of death and disability and the main cause of death among the under-45s. Most patients with moderate to severe TBI are admitted to intensive care units (ICUs)
The “PROSAFE” ICU network was recently established in 6 European countries through EU funding (PHEA 2007331), and has continued to collect high-quality data beyond the grant duration. In 2011, 225 ICUs had joined PROSAFE, recruiting a total of 73,163 patients, 2,694 of whom were admitted for TBI. Hence the network can expect to enrol 7-9,000 moderate to severe TBI patients in 4 years. The PROSAFE consortium has already focused attention on TBI and has just started collecting additional information on this condition in order to develop a prognostic model to identify centres of excellence in TBI management
Aims of proposal are to consolidate the existing network in order to better describe the epidemiology of moderate-severe TBI in 7 countries (Greece has now joined the consortium); build a prognostic model based on short- and long-term outcome measures; identify most effective clinical interventions for optimally treating TBI patients, and recognize the determinants of optimal vs suboptimal performance
All TBI-CDEs endorsed by InTBIR will be collected, along with other items needed to develop a sensible prognostic model, permitting the consortium to join forces with international collaborative initiatives in the field
Availing of the coordinating institute’s biobank and consolidated expertise in biochemical and genetic biomarkers, the aim is to identify prognostic markers and underlying genetic factors influencing response to treatment and final outcome
The PROSAFE consortium is thus in a position to guarantee superior quality data collection in 7 countries and ensure it continues beyond the life of the project. These conditions are essential if the consortium is to contribute to Europe playing a key role in the success of the InTBIR initiative"

Invito a presentare proposte

FP7-HEALTH-2013-INNOVATION-1
Vedi altri progetti per questo bando

Meccanismo di finanziamento

CP-IP - Large-scale integrating project

Coordinatore

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Indirizzo
Via Mario Negri 2
20156 Milano
Italia
Tipo di attività
Research Organisations
Contributo UE
€ 2 386 582
Contatto amministrativo
Guido Bertolini (Dr.)

Partecipanti (8)

SEMMELWEIS EGYETEM
Ungheria
Contributo UE
€ 519 726
Indirizzo
Ulloi Utca 26
1085 Budapest
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Akos Csomos (Dr.)
WARSZAWSKI UNIWERSYTET MEDYCZNY
Polonia
Contributo UE
€ 478 470
Indirizzo
Ul. Zwirki I Wigury 61
02 091 Warszawa
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Malgorzata Mikaszewska- Sokolewicz (Dr.)
SPLOSNA BOLNISNICA NOVO MESTO
Slovenia
Contributo UE
€ 256 671
Indirizzo
Smihelska Ulica 1
8000 Novo Mesto
Tipo di attività
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Contatto amministrativo
Rafael Kaps (Dr.)
UNIVERZITETNI KLINICNI CENTER LJUBLJANA
Slovenia
Contributo UE
€ 337 671
Indirizzo
Zaloska Cesta 002
1000 Ljubljana
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Miha žemlja (Mr.)
EDEX - EDUCATIONAL EXCELLENCE CORPORATION LIMITED
Cipro
Contributo UE
€ 314 645
Indirizzo
Makedonitisas Avenue 46
1700 Nicosia
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Theodoros Kyprianou (Prof.)
BEN-GURION UNIVERSITY OF THE NEGEV
Israele
Contributo UE
€ 703 680
Indirizzo
.
84105 Beer Sheva
Tipo di attività
Higher or Secondary Education Establishments
Contatto amministrativo
Daphna Tripto (Ms.)
PANEPISTIMIAKO GENIKO NOSOKOMEIO IRAKLEIOU
Greece
Contributo UE
€ 374 625
Indirizzo
Voutes
71110 Irakleio
Tipo di attività
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Contatto amministrativo
Dimitris Georgopoulos (Prof.)
OROBIX SRL
Italia
Contributo UE
€ 71 280
Indirizzo
Via Gabriele Camozzi 144
24121 Bergamo
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo
Luca Antiga (Dr.)